5326492025-01-012025-03-315326492025-03-315326492024-03-315326492024-04-012025-03-315326492025-01-012025-03-31in-capmkt:OtherExpenses1Member5326492024-04-012025-03-31in-capmkt:OtherExpenses1Member5326492025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326492024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15326492025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532649NECLIFENOTLISTEDINE023H01027Nectar Lifesciences LimitedMain BoardEquity2024-04-012025-03-312025-07-072025-07-03INRLakhsQuarterlyFourth quarterSingle segmentPharmaceutical Business Segment.2025-07-0719:40:002025-07-0722:10:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated43069460007770004307723000405698900009688400002380700001767200001576690005860850006184373000-18766500000-18766500000-575758000-5757580000-13008920000000-13008920005398000-12954940002242610001-5.8-5.800-5.8-5.8Notes: <BR> <BR> 1. The above financial results were reviewed by Audit Committee on July 7, 2025 and approved by the Board in its meeting held on July 7, 2025 and further Audited by the Statutory Auditors of the Company. The auditor's report is attached alongwith these results. The Board of Directors hereby declare that audit reports do not contain any modified opinion. <BR> <BR> 2.The company is exclusively in the pharmaceutical business segment. <BR> <BR> 3. Previous year figures have been regrouped and reclassified wherever necessary to make them comparable with current period. <BR> <BR> 4.The figures of the last quarter for the current year and for the previous year are the balancing figures between the audited figure in respect of the full financial year ended March 31 and the unaudited published year to date figures upto the third quarter ended December 31 which was subject to limited review. <BR> <BR> 5.The Company Nectar Lifesciences Limited is Not a Large Corporate as per the framework provided in the SEBI Circular dated October 19, 2023 on Fund raising by issuance of debt securities by Large Entities. <BR> <BR> 6. During the financial year 2020-21, the Company engaged an independent technical expert-nominated by the Lead Bank under the Agency for Special Monitoring to perform a comprehensive quality assessment of certain raw materials and work in progress batches. Based on expert’s findings, the Company reclassified inventory totaling Rs. 25,108.73 lakhs from inventories current to Non-Current Assets. <BR> <BR> Notwithstanding the reports furnished by technical expert about the remaining non-current inventory, the management has, adhering to conservatism principle, decided to mark down the realizable value of inventory to Rs. 5,061.27 lakhs from Rs.17,733.10 lakhs, based on the fact that the inventory has been in stocks for a considerable period. The resultant loss has been charged to profit and loss account in the fourth quarter. The management is confident that the value remaining after mark down is realizable. <BR> <BR> The classification and measurement of net realizable value reflect significant management judgements and estimates concerning market demand, processing yields and future selling prices. These estimates are inherently uncertain and actual outcome may differ. Accordingly, the company periodically reviews and adjusts carrying amounts as warranted by changing conditions. <BR> 2024-04-012025-03-31AuditedConsolidated1673074300018909000167496520001250722600001172869000964746000745783000623894000235047400018364992000-16153400000-16153400000-478532000-4785320000-11368080000000-11368080005398000-113141000022426100019936807000-5.07-5.0700-5.07-5.07Other Expenses586085000Other Expenses2350474000576604600056728300005650430002351000848710000325120001197340005504100005278620008096378000690159600052950003454847000192216000085690007512200037360490001738224000123758690002047224700022426100093368070009561068000956106800060127300060127300087284000720800069576500052189540008755400042936080004381162000497727000100978430008835000029221000102154140001091117900020472247000Note: <BR> <BR> 1) The Other non-current assets of Rs.5278.62 Lacs includes the Non Current Inventory of Rs.5061.27 Lacs. <BR> <BR> 2) Previous year figures have been regrouped and reclassified wherever necessary to make them comparable with current period.7457830001463209000337088000-2330000-87792000-557000-408600066700001845510000-81415000-25000062389400007007000791500011042300000018561000000-20500082980001608100003309720000169438000000000169438000000000000830004379480000000000000000000001489400003667000-4193040000000000005328070002330000074578300000-1280920000-58440000-58440000-5844000Remeasurement of the net defined benefit liability/asset (Net of Tax)53980005398000Remeasurement of the net defined benefit liability/asset (Net of Tax)539800053980000053980005398000AuditedtrueDeepak Jindal & Co.true2027-05-31